Jonathan Lapin, PharmD

home / authors / jonathan-lapin-pharmd

Articles

Role of Immunosuppression on Community-Acquired Clostridioides difficile Risk

October 13th 2021

CDI remains an urgent public health threat and continues to be the most frequent cause of diarrhea among hospitalized patients and overall hospital-acquired infection in the United States.

Double Trouble: Assessing the Impact of Combining Daptomycin and Fosfomycin for MRSA Bacteremia

Jonathan Lapin, PharmD;Tiffany Lee, PharmD, BCIDP

September 18th 2020

This highlighted study looks at using these 2 therapies concurrently for this infection.

Published: August 27th 2024 | Updated: August 28th 2024

Concerns Over Mosquito-Borne Illness Causes Massachusetts Town to Create Curfew for Parks, Spraying in Counties

Published: March 9th 2022 | Updated: December 22nd 2024

Effects of Switching Antibiotics Mid-Treatment on Antimicrobial Resistance

Published: December 5th 2024 | Updated: December 22nd 2024

COVID-19 Therapy Roundtable: What is the Virus Today, Treatment Options, and Addressing the Pediatric Population

Published: December 19th 2024 | Updated: December 22nd 2024

COVID-19 Roundtable: Should Clinicians Consider Off Label COVID Therapies?

Published: December 17th 2024 | Updated: December 22nd 2024

Peer-Assisted Telemedicine Enables More People With Hepatitis C to Get into the Continuum of Care

Published: December 18th 2024 | Updated: December 22nd 2024

Ethical and Innovative Use of AI in Infectious Disease

Do Not Sell My Information

Privacy

Terms & Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

Jonathan Lapin, PharmD

Articles

Latest Updated Articles